{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:57:51Z","timestamp":1760821071026,"version":"3.44.0"},"reference-count":5,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,3,29]]},"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>Mesalazine (5-aminosalicylic acid)-based products are a widely used treatment for inflammatory bowel disease in children and adults. Associated myopericarditis is an uncommon but recorded phenomenon related to drug hypersensitivity. Unless recognised, this important complication may culminate in the development of dilated cardiomyopathy and severe heart failure. We report the case of a boy with Crohn\u2019s disease who developed myopericarditis 14 days after starting treatment with mesalazine. Discontinuation of the drug rapidly led to normalisation of left ventricular structure and function, and a parallel improvement in the levels of plasma N-terminal pro-B-type natriuretic peptide and other markers of myocardial damage. Clinicians should be aware of this potentially life-threatening adverse effect of mesalazine therapy, which is quickly and fully reversible on cessation of the agent.<\/jats:p>","DOI":"10.1136\/bcr-2018-229142","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T14:45:19Z","timestamp":1554993919000},"page":"e229142","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma N-terminal pro-B-type natriuretic peptide (BNP) in mesalazine-induced myopericarditis"],"prefix":"10.1136","volume":"12","author":[{"given":"Theodoros","family":"Paschalis","sequence":"first","affiliation":[{"name":"University of Cambridge School of Clinical Medicine, Cambridge, Cambridgeshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrella","family":"Paschali","sequence":"additional","affiliation":[{"name":"Medical Faculty, Heinrich Heine University, Dusseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit K J","family":"Mandal","sequence":"additional","affiliation":[{"name":"Cardiology and Medicine, Frimley Health NHS Foundation Trust, Slough, Berkshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos G","family":"Missouris","sequence":"additional","affiliation":[{"name":"Cardiology and Medicine, Frimley Health NHS Foundation Trust, Slough, Berkshire, UK"},{"name":"Medical School, University of Cyprus, Nicosia, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,4,11]]},"reference":[{"key":"2025082800311248000_12.4.e229142.1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2169\/internalmedicine.40.901","article-title":"Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis","volume":"40","author":"Ishikawa","year":"2001","journal-title":"Intern Med"},{"key":"2025082800311248000_12.4.e229142.2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.4400"},{"key":"2025082800311248000_12.4.e229142.3","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.5.391.33188"},{"key":"2025082800311248000_12.4.e229142.4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1017\/S1047951114001048","article-title":"Mesalamine-induced myopericarditis in a paediatric patient with Crohn\u2019s disease","volume":"25","author":"Nair","year":"2015","journal-title":"Cardiol Young"},{"key":"2025082800311248000_12.4.e229142.5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/cs0940591","article-title":"How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines","volume":"94","author":"Missouris","year":"1998","journal-title":"Clin Sci"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-229142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:31:17Z","timestamp":1756366277000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-229142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":5,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,11]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1136\/bcr-2018-229142"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-229142","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}